Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

2 Résultats
authFullName_s : L. Siproudhis

Which second-line biologic after anti-TNF failure during Crohn's disease: Ustekinumab or vedolizumab, a multicentre retrospective study

C. Rayer , X. Roblin , D. Laharie , Benoît Caron , M. Flamant , et al.
Journal of Crohn's and Colitis, 2020, 14 (1), pp.S547. ⟨10.1093/ecco-jcc/jjz203.793⟩
Article dans une revue hal-03551537v1

Efficacy of ustekinumab in perianal Crohn's disease: the BioLAP multi-centre observational study

C. Biron , P. Seksik , M. Nachury , Y. Bouhnik , A. Amiot , et al.
14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.108⟩
Communication dans un congrès hal-03552295v1